Vigabatrin: visual field defects

被引：0

作者：

机构：

来源：

Reactions Weekly | 2001年 / 875卷 / 1期

关键词：

Public Health; Visual Field; Vigabatrin; Visual Field Defect; Dose Dependence;

D O I：

10.2165/00128415-200108750-00013

中图分类号：

学科分类号：

摘要：

引用

页码：5 / 5

共 50 条

[41] PREVALENCE OF VISUAL FIELD DEFECTS FOLLOWING EXPOSURE TO VIGABATRIN THERAPY: A SYSTEMATIC REVIEW
Maguire, M. J.
Hemming, K.
Hutton, J. L.
Marson, A. G.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (04): : 460 - 460
[42] Predictability of visual field defects in patients exposed to GABAergic agents, vigabatrin, or tiagabine
Beran, RG
Hung, A
Plunkett, M
Currie, J
Sachinwalla, T
NEUROLOGY, 1999, 52 (06) : A249 - A249
[43] PREVALENCE OF VISUAL FIELD DEFECTS FOLLOWING EXPOSURE TO VIGABATRIN THERAPY: A SYSTEMATIC REVIEW
Maguire, M.
Hemming, K.
Hutton, J.
Marson, A.
EPILEPSIA, 2009, 50 : 191 - 191
[44] GABA and the ornithine δ-aminotransferase gene in vigabatrin-associated visual field defects
Hisama, FM
Mattson, RH
Lee, HH
Felice, K
Petroff, OAC
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2001, 10 (07): : 505 - 507
[45] Tangent screens are still useful in the assessment of vigabatrin induced visual field defects
Olson, JA
Purdie, AT
Coleman, RJ
BRITISH JOURNAL OF OPHTHALMOLOGY, 2002, 86 (08) : 931 - 932
[46] The natural history of Vigabatrin associated visual field defects in patients electing to continue their medication
Best, JL
Acheson, JF
EYE, 2005, 19 (01) : 41 - 44
[47] Investigating visual field defects after exposure to vigabatrin: the use of pupil perimetry.
Tomlin, EA
Bremner, FD
Acheson, JF
Smith, SE
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S848 - S848
[48] Vigabatrin use appears to be associated with visual field defects (VFDs) in paediatric patients with epilepsy
Reactions Weekly, 2006, 1120 (1) : 3 - 3
[49] Vigabatrin treatment and visual field loss
Catherine Chiron
Olivier Dulac
Nature Reviews Neurology, 2011, 7 : 189 - 190
[50] Interim report on the incidence of visual field defects in patients on long term vigabatrin therapy
Wilton, LV
Stephens, MDB
Mann, RD
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 1999, 8 : S9 - S14

← 1 2 3 4 5 →